Scientific Session 9: Basic Science: Big Data research
Sebastian Zeissig, Dresden, Germany
Laurence Egan, Galway, Ireland

55: OP32: Mincle signaling promotes intestinal mucosal inflammation through induction of macrophage pyroptosis and neutrophil chemotaxis in Crohn's Disease
CANCELLED

Scientific Session 10: Multidisciplinary cases
Dan Turner, Jerusalem, Israel
Marc Ferrante, Leuven, Belgium
Pierre Michetti, Lausanne, Switzerland
Yves Panis, Clichy, France
Frank Ruemmele, Paris, France

DOP15: Transmural healing with vedolizumab in patients with active Crohn's Diesease
Shaji Adsul

DOP16: An evaluation of the exposure-efficacy relationship for subcutaneous vedolizumab maintenance treatment of Chron's Diesease: Pharmacokinetic findings from VISIBLE 2
Maria Rosario

DOP19: Real-world healthcare resource utilisation among patients with Inflammatory Bowel Disease administered vedolizumab for 6 months
Jason Rogers, New York, United States

DOP23: Endoscopic evaluation at one month after Ileocolic resection for Crohn's Disease predicts postoperative recurrence and is safe
CANCELLED

DOP49: Quantitative proteomics analysis of macrophages from Crohn's Disease patients and infected with adherent-invasive Escherichia coli
Anthony Buisson, Clermont-Ferrand, France

DOP66: A CEACAM5 small peptide restores the suppressive activity of CD8 + T cells in patients with Crohn's Disease
Stefania Vetrano, Rozzano, Italy

DOP68: Thiomyristoyl Ameliorates Colitis by blocking the differentiation of Th17 Cells via STAT3/IL-6 Signal Pathway
CANCELLED

DOP90: The role of Nlrp9b, a novel NLR member in regulating experimental colitis
CANCELLED

Whole blood TREM-1, marker of anti-TNF non-responsiveness in IBD
Bram Verstockt, Leuven, Belgium

N01:Factors related to self-medication with corticosteroids, aminosalicylates or analgesics and reasons given by patients with Ulcerative Colitis from Spain

Sabela Fernandez, Madrid, Spain